Clinical Trial Update: Metabolic Effects of Antipsychotic Substitution in Children [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial examining metabolic effects of switching antipsychotics in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Washington University School of Medicine | Conditions: Diabetes | Phase 2, Phase 3 | Status: WITHDRAWN